PTH and chronic kidney disease: There are several medical therapies that help to keep phosphorus and parathyroid hormone blood levels within the target range, and in 2004, the drug cinacalcet hydrochloride (cinacalcet) was approved in the United States for use in people with end-stage CKD for this purpose.